Table 4 Postoperative metastatic patterns of patients with stage III colon cancer after curative treatment
Metastatic parameters | Standard XELOX (n = 126, %) | Modified XELOX (n = 84, %) | Unfinished XELOX (n = 120, %) | P value 1 | P value 2 |
|---|---|---|---|---|---|
Postoperative metastasis | Â | Â | Â | 0.861 | 0.046 |
 Present | 23 (18.3) | 14 (16.7) | 35 (29.2) |  |  |
 Absent | 103 (81.7) | 70 (83.3) | 85 (70.8) |  |  |
Liver metastasis | Â | Â | Â | 0.821 | 0.798 |
 Present | 8 (6.3) | 6 (7.1) | 11 (9.2) |  |  |
 Absent | 118 (93.7) | 78 (92.9) | 109 (90.8) |  |  |
Lung metastasis | Â | Â | Â | 0.570 | 0.739 |
 Present | 9 (7.1) | 4 (4.8) | 7 (5.8) |  |  |
 Absent | 117 (92.9) | 80 (95.2) | 113 (94.2) |  |  |
Abdominopelvic metastasis | Â | Â | Â | 0.735 | 0.017 |
 Present | 4 (3.2) | 2 (2.4) | 14 (11.7) |  |  |
 Absent | 122 (96.8) | 82 (97.6) | 106 (88.3) |  |  |